FISH versus real-time quantitative PCR for monitoring of minimal residual disease in chronic myeloid leukaemia patients on tyrosine kinase inhibitor therapy.

MLA

Haidary, A. M., et al. “FISH versus Real-Time Quantitative PCR for Monitoring of Minimal Residual Disease in Chronic Myeloid Leukaemia Patients on Tyrosine Kinase Inhibitor Therapy.” The Malaysian Journal of Pathology, vol. 41, no. 2, Aug. 2019, pp. 149–60. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=31427550&authtype=sso&custid=ns315887.

APA

Haidary, A. M., Azma, R. Z., Ithnin, A., Alauddin, H., Tumian, N. R., Tamil, A. M., Razak, N. F. A., Abu Amis, S. H., Zin, N. M., & Shuib, S. (2019). FISH versus real-time quantitative PCR for monitoring of minimal residual disease in chronic myeloid leukaemia patients on tyrosine kinase inhibitor therapy. The Malaysian Journal of Pathology, 41(2), 149–160.

Chicago

Haidary, A M, R Z Azma, A Ithnin, H Alauddin, N R Tumian, A M Tamil, N F A Razak, S H Abu Amis, N M Zin, and S Shuib. 2019. “FISH versus Real-Time Quantitative PCR for Monitoring of Minimal Residual Disease in Chronic Myeloid Leukaemia Patients on Tyrosine Kinase Inhibitor Therapy.” The Malaysian Journal of Pathology 41 (2): 149–60. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=31427550&authtype=sso&custid=ns315887.